CCX832 inhibits these effects by downregulating tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2), highlighting chemerin’s role in enhancing cancer cell invasiveness [39]. This evidence concerns the gene RARRES2 and cancer.